Fundraising FoxWren Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
PharmEnablepharmenable.cominMay 2023 · $7.5M
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesO2h VenturesParkwalk Advisors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.